Gyre Therapeutics, Inc.
Pharmaceutical company · San Diego, California, United States · Nasdaq: GYRE
Gyre Therapeutics, Inc. is a pharmaceutical company headquartered in San Diego, California, United States. Its shares trade on Nasdaq under the ticker GYRE. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2023.
Gyre Therapeutics at a glance
What does Gyre Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $5 million sold (2023).
Frequently asked questions about Gyre Therapeutics
Where is Gyre Therapeutics headquartered?
Gyre Therapeutics, Inc. is headquartered in San Diego, California, United States.
What does Gyre Therapeutics do?
Gyre Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Gyre Therapeutics a public company?
Yes. Gyre Therapeutics, Inc. trades on Nasdaq under the ticker GYRE.
Similar companies
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Oncternal Therapeutics, Inc.San Diego, California, United States
- Acadia Pharmaceuticals IncSan Diego, California, United States
- ViaCyte Inc.San Diego, California, United States
- Avidity Biosciences, Inc.San Diego, California, United States
- Ligand Pharmaceuticals IncSan Diego, California, United States
- Arena Pharmaceuticals IncSan Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences